An image fusion system for estimating the therapeutic effects of radiofrequency ablation on hepatocellular carcinoma

1Tiong L, Maddern GJ. Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma. Br J Surg 2011; 98: 1210-24. 10.1002/bjs.7669TiongL MaddernGJ. Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma Br J Surg2011 98 121024 10.1002/bjs.7669Open DOISearch in Google Scholar

2Nouso K, Shiraga K, Uematsu S, Okamoto R, Harada R, Takayama S, et al. Prediction of the ablated area by the spread of microbubbles during radiofrequency ablation of hepatocellular carcinoma. Liver Int 2005; 25: 967-72. 10.1111/j.1478-3231.2005.01145.xNousoK ShiragaK UematsuS OkamotoR HaradaR TakayamaS Prediction of the ablated area by the spread of microbubbles during radiofrequency ablation of hepatocellular carcinoma Liver Int2005 25 96772 10.1111/j.1478-3231.2005.01145.xOpen DOISearch in Google Scholar

3Koda M, Mandai M, Matono T, Sugihara T, Nagahara T, Ueki M, et al. Assessment of the ablated area after radiofrequency ablation by the spread of bubbles: comparison with virtual sonography with magnetic navigation. Hepatogastroenterology 2011; 58: 1638-42. 10.5754/hge08641KodaM MandaiM MatonoT SugiharaT NagaharaT UekiM Assessment of the ablated area after radiofrequency ablation by the spread of bubbles: comparison with virtual sonography with magnetic navigation Hepatogastroenterology2011 58 163842 10.5754/hge08641Open DOISearch in Google Scholar

4Minami Y, Kudo M. Ultrasound fusion imaging of hepatocellular carcinoma: a review of current evidence. Dig Dis 2014; 32: 690-5. 10.1159/000368001MinamiY KudoM Ultrasound fusion imaging of hepatocellular carcinoma: a review of current evidence Dig Dis2014 32 6905 10.1159/000368001Open DOISearch in Google Scholar

5Toshikuni N, Tsutsumi M, Takuma Y, Arisawa T. Real-time image fusion for successful percutaneous radiofrequency ablation of hepatocellular carcinoma. J Ultrasound Med 2014; 33: 2005-10. 10.7863/ultra.33.11.2005ToshikuniN TsutsumiM TakumaY ArisawaT Real-time image fusion for successful percutaneous radiofrequency ablation of hepatocellular carcinoma J Ultrasound Med2014 33 200510 10.7863/ultra.33.11.2005Open DOISearch in Google Scholar

6Kawasoe H, Eguchi Y, Mizuta T, Yasutake T, Ozaki I, Shimonishi T, et al. Radiofrequency ablation with the real-time virtual sonography system for treating hepatocellular carcinoma difficult to detect by ultrasonography. J Clin Biochem Nutr 2007; 40: 66-72. 10.3164/jcbn.40.66KawasoeH EguchiY MizutaT YasutakeT OzakiI ShimonishiT Radiofrequency ablation with the real-time virtual sonography system for treating hepatocellular carcinoma difficult to detect by ultrasonography J Clin Biochem Nutr2007 40 6672 10.3164/jcbn.40.66Open DOISearch in Google Scholar

7Kitada T, Murakami T, Kuzushita N, Minamitani K, Nakajo K, Osuga K, et al. Effectiveness of real-time virtual sonography-guided radiofrequency ablation treatment for patients with hepatocellular carcinomas. Hepatol Res 2008; 38: 565-71. 10.1111/j.1872-034X.2007.00308.xKitadaT MurakamiT KuzushitaN MinamitaniK NakajoK OsugaK Effectiveness of real-time virtual sonography-guided radiofrequency ablation treatment for patients with hepatocellular carcinomas Hepatol Res2008 38 56571 10.1111/j.1872-034X.2007.00308.xOpen DOISearch in Google Scholar

8Minami Y, Chung H, Kudo M, Kitai S, Takahashi S, Inoue T, et al. Radiofrequency ablation of hepatocellular carcinoma: value of virtual CT sonography with magnetic navigation. AJR Am J Roentgenol 2008; 190: W335-41. 10.2214/ajr.07.3092MinamiY ChungH KudoM KitaiS TakahashiS InoueT Radiofrequency ablation of hepatocellular carcinoma: value of virtual CT sonography with magnetic navigation AJR Am J Roentgenol2008 190 W33541 10.2214/ajr.07.3092Open DOISearch in Google Scholar

9Nakai M, Sato M, Sahara S, Takasaka I, Kawai N, Minamiguchi H, et al. Radiofrequency ablation assisted by real-time virtual sonography and CT for hepatocellular carcinoma undetectable by conventional sonography. Cardiovasc Intervent Radiol 2009; 32: 62-9. 10.1007/s00270-008-9462-xNakaiM SatoM SaharaS TakasakaI KawaiN MinamiguchiH Radiofrequency ablation assisted by real-time virtual sonography and CT for hepatocellular carcinoma undetectable by conventional sonography Cardiovasc Intervent Radiol2009 32 629 10.1007/s00270-008-9462-xOpen DOISearch in Google Scholar

10Lee MW, Rhim H, Cha DI, Kim YJ, Choi D, Kim YS, et al. Percutaneous radiofrequency ablation of hepatocellular carcinoma: fusion imaging guidance for management of lesions with poor conspicuity at conventional sonography. AJR Am J Roentgenol 2012; 198: 1438-44. 10.2214/ajr.11.7568LeeMW RhimH ChaDI KimYJ ChoiD KimYS Percutaneous radiofrequency ablation of hepatocellular carcinoma: fusion imaging guidance for management of lesions with poor conspicuity at conventional sonography AJR Am J Roentgenol2012 198 143844 10.2214/ajr.11.7568Open DOISearch in Google Scholar

11Song KD, Lee MW, Rhim H, Cha DI, Chong Y, Lim HK. Fusion imaging-guided radiofrequency ablation for hepatocellular carcinomas not visible on conventional ultrasound. AJR Am J Roentgenol 2013; 201: 1141-7. 10.2214/ajr.13.10532Song KD Lee MW RhimH ChaDI ChongY LimHK Fusion imaging-guided radiofrequency ablation for hepatocellular carcinomas not visible on conventional ultrasound AJR Am J Roentgenol2013 201 11417 10.2214/ajr.13.10532Open DOISearch in Google Scholar

12Ahn SJ, Lee JM, Lee DH, Lee SM, Yoon JH, Kim YJ, et al. Real-time US-CT/MR Fusion Imaging for Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma. J Hepatol 2016. 10.1016/j.jhep.2016.09.003AhnSJ LeeJM LeeDH LeeSM YoonJH KimYJ Real-time US-CT/MR Fusion Imaging for Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma J Hepatol 2016 10.1016/j.jhep.2016.09.003Open DOISearch in Google Scholar

13Bruix J, Sherman M, Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208-36. 10.1002/hep.20933BruixJ ShermanM Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma Hepatology2005 42 120836 10.1002/hep.20933Open DOISearch in Google Scholar

14Hatanaka K, Kudo M, Minami Y, Ueda T, Tatsumi C, Kitai S, et al. Differential diagnosis of hepatic tumors: value of contrast-enhanced harmonic sonography using the newly developed contrast agent, Sonazoid. Intervirology 2008; 51(Suppl 1): 61-9. 10.1159/000122600HatanakaK KudoM MinamiY UedaT TatsumiC KitaiS Differential diagnosis of hepatic tumors: value of contrast-enhanced harmonic sonography using the newly developed contrast agent, Sonazoid Intervirology2008 51 (Suppl 1) 619 10.1159/000122600Open DOISearch in Google Scholar

15Toshikuni N, Shiroeda H, Ozaki K, Matsue Y, Minato T, Nomura T, et al. Advanced ultrasonography technologies to assess the effects of radiofrequency ablation on hepatocellular carcinoma. Radiol Oncol 2013; 47: 224-9. 10.2478/raon-2013-0033ToshikuniN ShiroedaH OzakiK MatsueY MinatoT NomuraT Advanced ultrasonography technologies to assess the effects of radiofrequency ablation on hepatocellular carcinoma Radiol Oncol2013 47 2249 10.2478/raon-2013-0033Open DOISearch in Google Scholar

16Kudo M, Izumi N, Kokudo N, Matsui O, Sakamoto M, Nakashima O, et al. Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version. Dig Dis 2011; 29: 339-64. 10.1159/000327577KudoM IzumiN KokudoN MatsuiO SakamotoM NakashimaO Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version Dig Dis2011 29 33964 10.1159/000327577Open DOISearch in Google Scholar

17Minami T, Minami Y, Chishina H, Arizumi T, Takita M, Kitai S, et al. Combination guidance of contrast-enhanced US and fusion imaging in radiofrequency ablation for hepatocellular carcinoma with poor conspicuity on contrast-enhanced US/fusion imaging. Oncology 2014; 87(Suppl 1): 55-62. 10.1159/000368146MinamiT MinamiY ChishinaH ArizumiT TakitaM KitaiS Combination guidance of contrast-enhanced US and fusion imaging in radiofrequency ablation for hepatocellular carcinoma with poor conspicuity on contrast-enhanced US/fusion imaging Oncology2014 87 (Suppl 1) 5562 10.1159/000368146Open DOISearch in Google Scholar

18Uehara T, Hirooka M, Ishida K, Hiraoka A, Kumagi T, Kisaka Y, et al. Percutaneous ultrasound-guided radiofrequency ablation of hepatocellular carcinoma with artificially induced pleural effusion and ascites. J Gastroenterol 2007; 42: 306-11. 10.1007/s00535-006-1949-0UeharaT HirookaM IshidaK HiraokaA KumagiT KisakaY Percutaneous ultrasound-guided radiofrequency ablation of hepatocellular carcinoma with artificially induced pleural effusion and ascites J Gastroenterol2007 42 30611 10.1007/s00535-006-1949-0Open DOISearch in Google Scholar

19Takuma Y, Takabatake H, Morimoto Y, Toshikuni N, Kayahara T, Makino Y, et al. Comparison of combined transcatheter arterial chemoembolization and radiofrequency ablation with surgical resection by using propensity score matching in patients with hepatocellular carcinoma within Milan criteria. Radiology 2013; 269: 927-37. 10.1148/radiol.13130387TakumaY TakabatakeH MorimotoY ToshikuniN KayaharaT MakinoY Comparison of combined transcatheter arterial chemoembolization and radiofrequency ablation with surgical resection by using propensity score matching in patients with hepatocellular carcinoma within Milan criteria Radiology2013 269 92737 10.1148/radiol.13130387Open DOISearch in Google Scholar

20Kim YS, Lee WJ, Rhim H, Lim HK, Choi D, Lee JY. The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion. AJR Am J Roentgenol 2010; 195: 758-65. 10.2214/AJR.09.2954KimYS LeeWJ RhimH LimHK ChoiD LeeJY The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion AJR Am J Roentgenol2010 195 75865 10.2214/AJR.09.2954Open DOISearch in Google Scholar

21Hiraoka A, Hirooka M, Koizumi Y, Hidaka S, Uehara T, Ichikawa S, et al. Modified technique for determining therapeutic response to radiofrequency ablation therapy for hepatocellular carcinoma using US-volume system. Oncol Rep 2010; 23: 493-7.HiraokaA HirookaM KoizumiY HidakaS UeharaT IchikawaS Modified technique for determining therapeutic response to radiofrequency ablation therapy for hepatocellular carcinoma using US-volume system Oncol Rep2010 23 4937Search in Google Scholar

22Numata K, Fukuda H, Morimoto M, Kondo M, Nozaki A, Oshima T, et al. Use of fusion imaging combining contrast-enhanced ultrasonography with a perflubutane-based contrast agent and contrast-enhanced computed tomography for the evaluation of percutaneous radiofrequency ablation of hypervascular hepatocellular carcinoma. Eur J Radiol 2012; 81: 2746-53. 10.1016/j.ejrad.2011.11.052NumataK FukudaH MorimotoM KondoM NozakiA OshimaT Use of fusion imaging combining contrast-enhanced ultrasonography with a perflubutane-based contrast agent and contrast-enhanced computed tomography for the evaluation of percutaneous radiofrequency ablation of hypervascular hepatocellular carcinoma Eur J Radiol2012 81 274653 10.1016/j.ejrad.2011.11.052Open DOISearch in Google Scholar

23Minami Y, Minami T, Chishina H, Kono M, Arizumi T, Takita M, et al. US-US Fusion Imaging in Radiofrequency Ablation for Liver Metastases. Dig Dis 2016; 34: 687-91. 10.1159/000448857MinamiY MinamiT ChishinaH KonoM ArizumiT TakitaM US-US Fusion Imaging in Radiofrequency Ablation for Liver Metastases Dig Dis2016 34 68791 10.1159/000448857Open DOISearch in Google Scholar